These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9436556)

  • 1. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients.
    D'Ambra MN; Gray RJ; Hillman R; Jones JW; Kim HC; Rawitscher R; Schnaper H; Szymanski I; Vlahakes GJ; Kaplan D; Lynch KE; Guilfoyle M; Abels RI
    Ann Thorac Surg; 1997 Dec; 64(6):1686-93. PubMed ID: 9436556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin.
    Price TH; Goodnough LT; Vogler WR; Sacher RA; Hellman RM; Johnston MF; Bolgiano DC; Abels RI
    Am J Med; 1996 Aug; 101(2A):22S-27S. PubMed ID: 8928704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial.
    Feagan BG; Wong CJ; Kirkley A; Johnston DW; Smith FC; Whitsitt P; Wheeler SL; Lau CY
    Ann Intern Med; 2000 Dec; 133(11):845-54. PubMed ID: 11103054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: a randomized, double-blind, placebo-controlled, dose-ranging study.
    Mercuriali F; Inghilleri G; Biffi E; Colotti MT; Vinci A; Oriani G
    Acta Haematol; 1998; 100(2):69-76. PubMed ID: 9792935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
    Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
    Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
    Scott SN; Boeve TJ; McCulloch TM; Fitzpatrick KA; Karnell LH
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1221-9. PubMed ID: 12169903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of epoetin alfa in critically ill patients.
    Corwin HL; Gettinger A; Fabian TC; May A; Pearl RG; Heard S; An R; Bowers PJ; Burton P; Klausner MA; Corwin MJ;
    N Engl J Med; 2007 Sep; 357(10):965-76. PubMed ID: 17804841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. GM/EPO MDS Study Group.
    Thompson JA; Gilliland DG; Prchal JT; Bennett JM; Larholt K; Nelson RA; Rose EH; Dugan MH
    Blood; 2000 Feb; 95(4):1175-9. PubMed ID: 10666187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients.
    de Andrade JR; Jove M; Landon G; Frei D; Guilfoyle M; Young DC
    Am J Orthop (Belle Mead NJ); 1996 Aug; 25(8):533-42. PubMed ID: 8871751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty.
    Stowell CP; Chandler H; Jové M; Guilfoyle M; Wacholtz MC
    Orthopedics; 1999 Jan; 22(1 Suppl):s105-12. PubMed ID: 9927110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.
    Littlewood TJ; Bajetta E; Nortier JW; Vercammen E; Rapoport B;
    J Clin Oncol; 2001 Jun; 19(11):2865-74. PubMed ID: 11387359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of perioperative epoetin alfa in patients scheduled for elective hip surgery.
    Laupacis A
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):51-3; discussion 54. PubMed ID: 8723583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
    Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
    Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST).
    Weber EW; Slappendel R; Hémon Y; Mähler S; Dalén T; Rouwet E; van Os J; Vosmaer A; van der Ark P
    Eur J Anaesthesiol; 2005 Apr; 22(4):249-57. PubMed ID: 15892401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma.
    Dammacco F; Castoldi G; Rödjer S
    Br J Haematol; 2001 Apr; 113(1):172-9. PubMed ID: 11328297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.
    Garton JP; Gertz MA; Witzig TE; Greipp PR; Lust JA; Schroeder G; Kyle RA
    Arch Intern Med; 1995 Oct; 155(19):2069-74. PubMed ID: 7575066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy.
    Dammacco F; Silvestris F; Castoldi GL; Grassi B; Bernasconi C; Nadali G; Perona G; De Laurenzi A; Torelli U; Ascari E; Rossi Ferrini PL; Caligaris-Cappio F; Pileri A; Resegotti L
    Int J Clin Lab Res; 1998; 28(2):127-34. PubMed ID: 9689556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of Epoetin alfa in complex spine deformity surgery.
    Shapiro GS; Boachie-Adjei O; Dhawlikar SH; Maier LS
    Spine (Phila Pa 1976); 2002 Sep; 27(18):2067-71. PubMed ID: 12634571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy.
    Cortesi E; Mancuso A; De Pasquale Ceratti A; Pizzardi N; D'Auria G; Accettura C; Beccaglia P; Bertelletti D; De Marinis F
    Oncologist; 2004; 9(4):459-68. PubMed ID: 15266099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.